Clementia Pharmaceuticals's ROA from the fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Clementia Pharmaceuticals's ROA in the fourth quarter of 2018?
Clementia Pharmaceuticals Inc. recorded a cumulative net loss of $-58 million during 12 months ending in the fourth quarter of 2018, resulting in a negative return on assets (ROA) of -38.48%.

However, within the Healthcare sector 436 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2018 from to 4585.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter	(Jun 30 2018) II. Quarter	(Mar 31 2018) I. Quarter	(Dec 31 2017) IV. Quarter
Y / Y Total Assets Change	2.77 %	-37.17 %	-18.89 %	-19.33 %	759.06 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-58	-51	-75	-87	-115
Return On Assets (TTM)	-38.48 %	-33.81 %	-44.83 %	-50.09 %	-63.19 %
CMTA's Total Ranking	# 4585	#	#	#	#
Total Assets (TTM) in million	219	117	130	139	213
Seq. Total Assets Change	87.67 %	-10.12 %	-6.54 %	-34.8 %	14.73 %
Seq. Net Income Change	-	-	-	-	-

CMTA's 5 Years Annual ROA >> Back to CMTA Management Effectiveness >> Compare CMTA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 193
Sector	# 437
Overall	# 4374

Return On Assets Statistics
High	Average	Low
-32.87 %	-32.87 %	-32.87 %
(Dec 31 2018)

Financial Statements
Clementia Pharmaceuticals's Assets	$ 219 million	CMTA's Balance sheet
Clementia Pharmaceuticals's Income	$ -19 million	Quarterly CMTA's Income Statement
CMTA's Income by Division		See CMTA's Income by Division

Annual Return On Assets	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	FY	FY	FY
Y / Y Total Assets Change	2.77 %	-	-	-	-
Total Assets in million	219	213	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-58	-115	0	0	0
Annual Return On Assets	-26.55 %	-54.2 %	-	-	-

CMTA's 5 Years Annual ROA >> Back to CMTA Management Effectiveness >> Compare CMTA ROA to its Competitors

More Return On Assets Ratios
CMTA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CMTA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CMTA's Competitors
Subscribers only: Roa for Clementia Pharmaceuticals's Suppliers
Subscribers only: Return On Assets for CMTA's Customers

You may also want to know
CMTA's Roi	CMTA's Inventory Turnover Ratio	CMTA's Growth Rates	CMTA's Dividend Comparisons
	CMTA's Profitability Ratios	CMTA's Asset Turnover Ratio	CMTA's Dividend Growth
CMTA's Roe	CMTA's Valuation Ratios	CMTA's Financial Strength Ratios	CMTA's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2018, within Healthcare Sector

ROA

Date modified: 2026-09-05T11:07:08+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.